Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid tumors. Alpha DaRT, initially developed at Tel Aviv University, was shown to be effective and safe for treating different types of cancer in multiple preclinical and clinical studies. Uzi Sofer (CEO of Alpha Tau Medical) was invited to present the revolutionary Alpha DaRT technology on Galatz Radio in July and revealed